L-Carnitine + Methionine + Inositol + Choline + B12 + B6 + NADH - Lipo-C FAT BLASTER

1 Identity

Fixed-ratio seven-component article, presented as an injectable solution: a zwitterionic quaternary ammonium acid, a free sulfur-containing amino acid, a cyclic polyol, a quaternary ammonium alcohol salt, a cobalt corrinoid coordination compound, a pyridine derivative salt and a reduced dinucleotide. No component of this article contains a peptide bond. The methionine component is a free amino acid, which is a monomer and not a peptide. Each component's identity is cross-referenced where a record exists; L-Carnitine and NAD+ have their own records in this catalog. Three of the seven names on this label are category names rather than molecule names, so each has to be resolved to a specific compound before anything can be tested. "B12" covers cyanocobalamin 1,355.388, hydroxocobalamin 1,346.377 and methylcobalamin 1,344.405 — three different molecules within 11 Da of each other. "B6" covers pyridoxine hydrochloride 205.638 and pyridoxal-5'-phosphate 247.143. "Choline" names a cation.

Sequence

Not applicable to any component; there is no sequence in this article and none is written.

Molecular formula

Per component; a mixture has no combined formula and none is written. L-carnitine C7H15NO3 (hydrochloride C7H16ClNO3; L-tartrate C18H36N2O12). L-methionine C5H11NO2S. Myo-Inositol C6H12O6. Choline chloride C5H14ClNO; choline bitartrate C9H19NO7. Cyanocobalamin C63H88CoN14O14P. Pyridoxine hydrochloride C8H12ClNO3 (free base C8H11NO3; pyridoxal-5'-phosphate C8H10NO6P). NADH C21H29N7O14P2 (disodium C21H27N7Na2O14P2). Cobalt is the one element-specific handle in this article, and it is used below: the corrinoid component is the only thing in the vial that carries it. Phosphorus is not a handle, because it is shared — the cyanocobalamin formula above carries one phosphorus atom and NADH carries two — so a phosphorus number cannot be read as either component on its own.

Average mass

Per component, on IUPAC 2021 abridged conventional atomic weights: L-carnitine 161.201; L-methionine 149.208; myo-inositol 180.156; choline chloride 139.623 (bitartrate 253.251); cyanocobalamin 1,355.388; pyridoxine hydrochloride 205.638 (free base 169.180); NADH 665.446 (disodium 709.409). NADH against NAD+ IS 665.446 against 663.430, a difference of 2.016 Da that is the whole redox state of that component, and a certificate quoting 663.43 for an article labeled NADH has reported the oxidized molecule. Worked example at a stated nominal per milliliter of 200 + 25 + 50 + 50 + 1 + 2 + 10 mg, 338 mg total solids: 1,240.687, 167.551, 277.537, 358.107, 0.738, 9.726 and 15.028 micromol — a 1,682-fold molar span from carnitine to cyanocobalamin. That composition is a stated nominal for arithmetic, not a market standard. No single blend molecular weight is printed; a mixture does not have one.

Monoisotopic mass

Per component, neutral: L-carnitine 161.1052; L-methionine 149.0510; myo-inositol 180.0634; choline chloride 139.0764; cyanocobalamin 1,354.5674; pyridoxine hydrochloride 205.0506; NADH 665.1248. Two components are permanently charged cations and are observed as [M]+ rather than [M+H]+, which is a one-proton, 1.008 Da systematic error if the template assumes protonation — the same class of error this catalog records against quaternary ammonium and pyridinium articles elsewhere.

Salt / variant note

(1) ratio: none standard; every observed presentation of this class differs. (2) "B12": cyanocobalamin against hydroxocobalamin against methylcobalamin, 1,355.388 / 1,346.377 / 1,344.405. (3) "B6": pyridoxine hydrochloride 205.638 against pyridoxal-5'-phosphate 247.143 — and this one is not cosmetic, because the phosphate form is a different molecule at a different mass, and it puts a third phosphorus-bearing component into a vial where phosphorus is already carried by the corrinoid and by NADH. (4) choline salt: chloride 139.623 against bitartrate 253.251, an 81 percent difference in gross weight per mole of cation. (5) NADH redox and salt: free acid 665.446, disodium 709.409, oxidized NAD+ 663.430. (6) CHIRALITY: L-carnitine against the D enantiomer, L-methionine against DL-methionine.

2 Class & testing panel

Form

Fixed-ratio blend

Testing panel

P6 — panel definitionfor each component whose molecule is actually named, with a P7 element wherever the label writes a vitamin letter instead of a molecule, because an unfixed identity is an undefined composition however familiar the abbreviation. Run per component and never once for the vial. The panel choice governs the whole certificate: net peptide content is not a measurand for any of the seven, and a certificate printing net peptide content, amino acid analysis as a content method, or an endotoxin figure derived from a peptide template has answered a question this article does not pose

3 Primary sources & evidence

The index reports the design and provenance of the literature, not a conclusion about effect.

Published literature exists for the individual components and is voluminous for several of them; it is graded on a component record where one exists and is cross-referenced rather than restated. None of it is literature about this seven-component mixture.

4 Storage & specification

Storage

Amber, light-tight vials, stored cold at the temperature carried on the specification, with solution pH controlled to that same specification. The article's controlling instabilities are photochemical and redox rather than thermal: the corrinoid component is light-sensitive, and NADH is the least stable species in the vial, oxidizing to NAD+ and degrading under acidic conditions, so amber containment, controlled pH and low temperature are formulation requirements rather than shipping preferences. Several components are hygroscopic as solids and are kept desiccated in that form.

Shelf life

The article is dated from its date of manufacture and carries the retest interval printed on its specification, set by the stability protocol run on this article rather than inherited from any component record. The compatibility question that protocol answers rather than assumes is whether a reduced dinucleotide and a cobalt corrinoid can share one solution over shelf life without redox exchange, since one component is a reducing species and the other carries a redox-active metal center. The stability-indicating attributes are per-component content, the measured ratio, NAD+ content in the NADH component, cobalt by ICP-MS, pH, color, and any new peak above 0.10 percent.